140 likes | 428 Views
MENOPAUSE AND THE CLIMACTERIUM. in a nutshell Prof Greta Dreyer. Definitions. Climacterium The time around the menopause when ovarian function decreases Menopause Last menstruation Diagnosed in retrospect after 6 months amenorrhoea. The effects of decreasing sex steroids. ESTROGEN
E N D
MENOPAUSE AND THE CLIMACTERIUM in a nutshell Prof Greta Dreyer
Definitions • Climacterium • The time around the menopause when ovarian function decreases • Menopause • Last menstruation • Diagnosed in retrospect after 6 months amenorrhoea
The effects of decreasing sex steroids ESTROGEN Genital organs Decreased menses Thinning Dryness Atrophy
The effects of decreasing sex steroids ESTROGEN NON genital organs Bone deminerization Collagen decrease Increase in LDL Brain contains ER…
The effects of decreasing sex steroids PROGESTERONE Genital organs Increases ER sensitivity Decreased cycle control Breast atrophy NON genital organs Adds to bone deminerization Largely unknown Adds to collagen decrease
Symptoms of the climacterium and early menopause Vasomotor instability (flushing, sweating) Psychological change (sleep, well-being, memory loss) Urogenital atrophy (vaginitis, dryness, bladder) Other (libido, skin, hair, etc)
Complications of the menopause BONE LOSS Osteoporosis with loss of height, kiphosis, pain, fractures CARDIOVASCULAR DISEASE Coronary heart disease Cerebral vascular incidents (due to atherosclerosis)
AIMS OF MANAGEMENT OF CLIMACTERIUM AND MENOPAUSE Manage Symptoms Safely Prevent Later Complications Determine individual risk profile Consider timing of interventions “Holistic”
MANAGEMENT OF CLIMACTERIUM AND MENOPAUSE Determine necessity and duration and route and timing and type of HT Evaluate complication risks of HT Evaluate necessity of alternative interventions lifestyle medication
Determine individual risk profile • Family history • Medical history • MEDICAL EXAMINATION • BP • BMI weight distribution • Gynaecological examination • SPECIAL TESTS • BMD • Lipid profile, CRP • Mammogram
Non HT treatment of symptoms Vasomotor instability General measures Antidepressants Psychological change General measures Antidepressants Urogenital atrophy Sexual activity lubricants
NON HT prevention of complications of the menopause BONE LOSS Calcium, exercise, prevention of fractures CARDIOVASCULAR DISEASE Lipid lowering with diet and statins Exercise, treatment of other risk factors, weight control, HT, smoking, DM